These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34633333)

  • 1. Upregulation of HOX genes promotes cell migration and proliferation in head and neck squamous cell carcinoma.
    Aguiar GM; Ramão A; Plaça JR; Simões SC; Scaraboto NV; Freitas-Castro F; Cardoso C; Sousa JF; Silva WA
    Tumour Biol; 2021; 43(1):263-278. PubMed ID: 34633333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of endoplasmic reticulum stress related signature in head and neck squamous carcinoma.
    Miao Y; Chen Q; Liu X; Bu J; Zhang Z; Liu T; Yue Z; Huang L; Sun S; Li H; Yang A; Yang Z; Chen C
    Sci Rep; 2024 Jul; 14(1):16972. PubMed ID: 39043683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis.
    Li W; Zhu Q; Zhang S; Liu L; Zhang H; Zhu D
    Oral Oncol; 2020 Dec; 111():104946. PubMed ID: 32763778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma.
    Tan M; Lin X; Chen H; Ye W; Yi J; Li C; Liu J; Su J
    PeerJ; 2023; 11():e15203. PubMed ID: 37090107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Zhou Y; Huang Q; Wu C; Xu Y; Guo Y; Yuan X; Xu C; Zhou L
    Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38063205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the regulatory interactions between mutated genes and homeobox genes in the head and neck cancer progression.
    Padam KSR; Chakrabarty S; Hunter KD; Radhakrishnan R
    Arch Oral Biol; 2024 Mar; 159():105872. PubMed ID: 38147801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
    Wang L; Jia Y; Jiang Z; Gao W; Wang B
    Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
    de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
    Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma.
    Liu S; Tian W; Li B
    J Comput Biol; 2020 Jan; 27(1):100-108. PubMed ID: 31460782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis.
    Cai F; Xu H; Song S; Wang G; Zhang Y; Qian J; Xu L
    Curr Protein Pept Sci; 2024; 25(7):577-585. PubMed ID: 38584528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered epigenetic regulation of homeobox genes in human oral squamous cell carcinoma cells.
    Marcinkiewicz KM; Gudas LJ
    Exp Cell Res; 2014 Jan; 320(1):128-43. PubMed ID: 24076275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway.
    Jia W; Chen S; Wei R; Yang X; Zhang M; Qian Y; Liu H; Lei D
    Sci Rep; 2023 Jul; 13(1):10956. PubMed ID: 37414830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
    Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S
    Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
    Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
    Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinoma.
    Li R; Nan X; Li M; Rahhal O
    Oncol Res; 2024; 32(8):1323-1334. PubMed ID: 39055892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma.
    Liu S; Wang S; Wang Z
    BMC Med Genomics; 2023 May; 16(1):110. PubMed ID: 37210507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.